Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Johnson and Johnson
Moodys
Baxter
Express Scripts

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Oltipraz

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Oltipraz: Patents, clinical trial progress, indications

Oltipraz is an investigational drug.

There have been 4 clinical trials for Oltipraz. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2014.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Liver Diseases, and Fatty Liver. The leading clinical trial sponsors are PharmaKing, CJ HealthCare Corporation, and Northwestern University.

There are three hundred and forty-nine US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Oltipraz
TitleSponsorPhase
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseasePharmaKingPhase 2
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and CirrhosisCJ HealthCare CorporationPhase 2

See all Oltipraz clinical trials

Clinical Trial Summary for Oltipraz

Top disease conditions for Oltipraz
Top clinical trial sponsors for Oltipraz

See all Oltipraz clinical trials

US Patents for Oltipraz

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oltipraz   See Pricing Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA)   See Pricing
Oltipraz   See Pricing Pyrazolopyrimidine compounds GLAXOSMITHKLINE LLC (Wilmington, DE)   See Pricing
Oltipraz   See Pricing Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof vTv Therapeutics LLC (High Point, NC)   See Pricing
Oltipraz   See Pricing Methods for the prevention and the treatment of rapidly progressive glomerulonephritis INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS DESCARTES (Paris, FR)   See Pricing
Oltipraz   See Pricing Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE)   See Pricing
Oltipraz   See Pricing Pyrazolopyridine sulfonamides as nematicides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE)   See Pricing
Oltipraz   See Pricing Compounds and compositions for treating HIV with derivatives of Betulin GLAXOSMITHKLINE LLC (Wilmington, New Castle, DE)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Oltipraz

Drugname Country Document Number Estimated Expiration Related US Patent
Oltipraz Austria 448323 2023-03-05   See Pricing
Oltipraz Australia 2004218354 2023-03-05   See Pricing
Oltipraz Australia 2006216545 2023-03-05   See Pricing
Oltipraz Australia 2009245838 2023-03-05   See Pricing
Oltipraz Australia 2013202475 2023-03-05   See Pricing
Oltipraz Brazil PI0408116 2023-03-05   See Pricing
Oltipraz Brazil PI0608314 2023-03-05   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Medtronic
Moodys
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.